Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Change in Receivables (2016 - 2025)

Sonoma Pharmaceuticals has reported Change in Receivables over the past 16 years, most recently at -$340000.0 for Q4 2025.

  • For Q4 2025, Change in Receivables rose 47.37% year-over-year to -$340000.0; the TTM value through Dec 2025 reached -$261000.0, down 24.29%, while the annual FY2025 figure was -$434000.0, 288.7% down from the prior year.
  • Change in Receivables for Q4 2025 was -$340000.0 at Sonoma Pharmaceuticals, down from $78000.0 in the prior quarter.
  • Over five years, Change in Receivables peaked at $596000.0 in Q4 2023 and troughed at -$2.1 million in Q1 2021.
  • A 5-year average of -$218050.0 and a median of -$17000.0 in 2024 define the central range for Change in Receivables.
  • Biggest five-year swings in Change in Receivables: skyrocketed 346.07% in 2024 and later tumbled 2488.89% in 2025.
  • Year by year, Change in Receivables stood at -$537000.0 in 2021, then soared by 46.18% to -$289000.0 in 2022, then surged by 306.23% to $596000.0 in 2023, then tumbled by 208.39% to -$646000.0 in 2024, then skyrocketed by 47.37% to -$340000.0 in 2025.
  • Business Quant data shows Change in Receivables for SNOA at -$340000.0 in Q4 2025, $78000.0 in Q3 2025, and $216000.0 in Q2 2025.